A Food and Drug Administration vaccine advisory committee meeting scheduled for March to select the strains to be included in next season’s flu shot has been canceled, a panel member said Wednesday.

The Food and Drug Administration (FDA) has abruptly cancelled a vaccine advisory meeting where members were slated to discuss influenza vaccine strains. The meeting was scheduled for March 13. Committee members received an email informing them of the cancellation on Wednesday afternoon with no rescheduling information and no reason given for the cancellation,